Martine Rothblatt is the chairman and CEO of United Therapeutics, a biotechnology company, and the author of Virtually Human: The Promise and Peril of Digital Immortality. The highest-paid female CEO in the U.S., Rothblatt is a transhumanist, well known for creating BINA48, a cyborg of her wife. Previously, as an attorney-entrepreneur, she was responsible for launching several satellite communications companies, including SiriusXM, where she served as chariman and CEO. In the 1990s, she entered the life sciences field by leading the International Bar Associations project to develop a draft Human Genome Treaty for the UN, and by founding United Therapeutics. Rothblatt's inventions transcend information technology and medicine, and most recently include an Alzheimer's cognitive enabler that uses mindware to process mindfiles so that a mindclone of a person's consciousness results. The potential and ethics of this technology is described in her latest book, Virtually Human. She is also the author of books on satellite communications technology, gender freedom, genomics, and xenotransplantation.
More About Martine Rothblatt
Futurist, pharma tycoon, satellite entrepreneur, philosopher. Martine Rothblatt, the highest-paid female executive in America, was born male. But that is far from the thing that defines her. Just ask her wife. Then ask the robot version of her wife.
Rothblatt wants to knock down the wall between biological and digital. Between life and death. What’s coming, she says, are digital clones.
Entrepreneur and medical ethicist Martine Rothblatt discusses the future of artificial consciousness.
Even if they aren’t flesh, “mindclones” deserve protection.
McFarland interviews Rothblatt about the potential and drawbacks of our digital selves living forever.
National correspondent Amy Harmon sits down to talk with the Bina48 about what it's like to be a robot. Video of the interview is found here.
Rothblatt’s newest project appears lifted from science fiction: disembodied but breathing human lungs, hissing away in dome-shaped incubators, part of a clinical trial attempting to mend donated but not-quite-accepted-for-transplant lungs so that they can actually be placed in living human beings.